The Possibility to Use Medications Purchased at the Expense of a Patient in Intensive Care Units of Healthcare Institutions
The purpose of the study: to identify a legally justified possibility for a patient (patient's relatives) to purchase a drug product (DP), which has not been purchased by a healthcare institution but is recommended by the doctor in charge «by lifesaving indication» as the most effective one.Mat...
Saved in:
| Main Authors: | O. Yu. Aleksandrova, A. A. Sokolov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
2017-09-01
|
| Series: | Общая реаниматология |
| Subjects: | |
| Online Access: | https://www.reanimatology.com/rmt/article/view/1605 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Artificial Intelligence (AI) and Drug-Induced and Idiosyncratic Cytopenia: The Role of AI in Prevention, Prediction, and Patient Participation
by: Emmanuel Andrès, et al.
Published: (2025-04-01) -
Chest Compression Skill Evaluation System Using Pose Estimation and Web-Based Application
by: Ryota Watanabe, et al.
Published: (2025-07-01) -
Factors associated with a positive shock index in the prehospital setting after major trauma
by: Tim Andrews, et al.
Published: (2025-07-01) -
Effects of Physical Fatigue on Cardiopulmonary Resuscitation Quality by Lifeguards: A Systematic Review and Meta-analysis
by: Filipe Maia
Published: (2023-11-01) -
Ceftriaxone-Induced Pancytopenia: A Case Report
by: Edin Karisik, et al.
Published: (2025-06-01)